InvestorsHub Logo
icon url

chinatown1980

10/28/16 12:17 PM

#81205 RE: sentiment_stocks #81203

Why is a "new approach" necessary?
icon url

forumreader35

10/28/16 12:25 PM

#81208 RE: sentiment_stocks #81203

Sounds like assistance for the TCR deep sequencing Dr. Liau presented about earlier this year.
icon url

BWIS

10/28/16 12:25 PM

#81209 RE: sentiment_stocks #81203

Maybe he's buying the movie rights? Funny and concerning that Dr Liau lists "The Big Short" as her favorite movie!!!
icon url

sentiment_stocks

10/28/16 12:41 PM

#81211 RE: sentiment_stocks #81203

Well it could be for that...

http://newsroom.ucla.edu/releases/ucla-researchers-create-a-promising-new-treatment-for-the-deadliest-form-of-brain-cancer

But in that combination they used, it didn't use Linda Liau's dendritic cell vaccine.
It used the chemotherapy drug decitabine and reprogrammed t cells. The t cells were reprogrammed with a gene targeting New York esophageal squamous carcinoma (NY-ESO-1).

However, in this study published in the summer of this year, they did use the DC vaccine with a PD-1 mAb blockade (like BMY's Opdivo).

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4951098/

So there's that.
icon url

AVII77

10/28/16 1:15 PM

#81219 RE: sentiment_stocks #81203

Any ideas what that new approach might be that Gagliano pledged $1m to UCLA on October 25, 2016 for?



That article is over 4 years old.